Envista Holdings Corp (NVST) research
Envista Holdings Corp- Sector
- Health Care
- Last price
- $23.46
- As of
Envista Holdings Corp (NVST): 7 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-17.
As of . Source: SEC EDGAR filings for NVST. Method and limitations.
Share the NVST intelligence card
See the full NVST dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for NVST on one page. Preview it with sample data, then open it live with a free account.
Preview the NVST dossierActive signals for NVST
- highCONSENSUS_BUY
3 tracked funds increased NVST this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +50% to NVST (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 53% of NVST (2026Q2)
- highINSTITUTIONAL_SURGE
D. E. Shaw & Co., Inc. added +1223% to NVST (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 19.9%, EPS $0.41 vs $0.3419 estimate
FREE, NO ACCOUNT
Every signal on NVST, as it fires
You are seeing 5 of 15 signals recorded on NVST since 2026-05-31.
The five above landed across 3 days. The other 10 were recorded on 3 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in NVST (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P.CUSIP 29415F104 · 2026Q2 | $41.2M | 0.05% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 29415F104 · 2026Q2 | $40.1M | 0.06% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 29415F104 · 2026Q2 | $30.2M | 0.01% | , |
| Point72 Asset Management, L.P.CUSIP 29415FAD6 · 2026Q2 | $17.2M | 0.02% | , |
| D. E. Shaw & Co., Inc.CUSIP 29415F104 · 2026Q2 | $6M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 29415F104 · 2026Q2 | $3.5M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 29415F104 · 2026Q2 | $1.5M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 29415F104 · 2026Q2 | $1.1M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, NVST
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
NVST against its peers
NVST's operating margin of 7.9% ranks in the 52nd percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | NVST | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.7B USD | 1.9B USD | 79 | 25 |
| Gross margin | 54.7% | 59.9% | 36 | 17 |
| Operating margin | 7.9% | 6.2% | 52 | 23 |
| Net margin | 1.7% | 5.5% | 37 | 25 |
| Return on equity | 1.5% | 10.4% | 30 | 24 |
| P / E | 83.8x | 32.2x | 91 | 16 |
Peers (25): IRTC, CRVL, OPCH, LIVN, ITGR, HAE, WAY, TMDX, ATRC, DOCS, MMSI, AVAH, TFX, RDNT, BKD, ACHC, PRVA, LNTH, WGS, CHE, MD, PACS, SEM, HIMS, INSP. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (NVST: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more NVST signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to NVSTand get the insider, 13F, options, and confluence read in one view.